Bimoptik Plus Romfarm cap. eye. solution 0.3mg/ml +5mg/ml fl. 3 ml No. 1

Bimoptik Plus Romfarm is the combined medicine which part are bimatoprost and Timololum a maleate, reducing the high intraocular pressure (VGD) due to joint action which gives the chance to reach more expressed effect in comparison with effect of each of substances separately.

Indications

Decrease in the intraocular pressure (VGD) at adult patients with an open angle glaucoma and intraocular hypertensia, at insufficient efficiency of monotherapy by medicines of group of beta blockers or analogs of prostaglandin for topical administration.

Structure

• 1 ml of drops eye, solution contains bimatoprost 0.3 mg of Timololum of 5.0 mg (in the form of Timololum of a maleate of 6.8 mg);
• excipients: citric acid monohydrate, sodium phosphate heptahydrate; sodium chloride, benzalkoniya chloride, 1 M solution of sodium of hydroxide or hydrochloric acid; the water purified.

Contraindication

Hypersensitivity to Timololum, a bimatoprost and/or the excipients which are a part of medicine.

Syndrome of hyperreactivity of airways, including bronchial asthma in stages of aggravation and the postponed episodes in the anamnesis, a serious chronic obstructive bronchopulmonary (HOBL) illness.

Route of administration

Recommended dose - 1 drop in a conjunctival sac of the affected eye of 1 times a day, in the morning or in the evening. It is necessary to apply at the same time every day.

, the following dose should be entered as it is planned. It is not recommended to exceed a dose - 1 introduction of 1 times a day.

Feature of application

As well as other ophthalmologic medicines, Bimoptik Plus Romfarm can get into a system blood-groove. Because of presence of Timololum, a beta and adrenergic component, various types of undesirable reactions (can be observed from a cardiovascular and respiratory system), as at application of system beta-blockers. Frequency of emergence of undesirable reactions at local prescribing of medicine is lower, than at system application.

Pregnant

Bimoptik Plus Romfarm should be applied during pregnancy only in urgent cases.

Drug patients should not appoint

aged up to 18 years.

Drivers

Bimoptik Plus Romfarm has insignificant influence on ability to steer motor transport or other mechanisms. As well as at use of other ophthalmologic medicines if when burying there is temporary misting of sight, it is necessary to wait until the sight is restored before steering motor transport or other mechanisms.

Overdose

About cases of overdose of medicine of Bimoptik Plus Romfarm at people of messages did not arrive.

in case of overdose should perform symptomatic and maintenance therapy.

Side effects

from the immune system: hypersensitivity reactions, including symptoms of allergic dermatitis, a Quincke's disease, an internal allergy.

Mental disorders: insomnia, nightmares

from nervous system: the headache, dizziness,

Storage conditions

in original packing at a temperature not above 25 °C.

out of children's reach.